Mankind Pharma shines on getting nod to invest up to Rs 500 crore in Mankind Medicare
Mankind Pharma is currently trading at Rs. 2569.20, up by 75.10 points or 3.01% from its previous closing of Rs. 2494.10 on the BSE.
The scrip opened at Rs. 2499.30 and has touched a high and low of Rs. 2,579.00 and Rs. 2499.25 respectively. So far 84377 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2726.75 on 15-Jul-2025 and a 52 week low of Rs. 1909.90 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 2,579.00 and Rs. 2,105.70 respectively. The current market cap of the company is Rs. 105894.59 crore.
The promoters holding in the company stood at 72.66%, while Institutions and Non-Institutions held 24.66% and 2.68% respectively.
Mankind Pharma has received approval to make additional investment of up to Rs 500 crore in Mankind Medicare, a wholly owned subsidiary, in one or more tranches. The funds will be utilized for capacity expansion and plant being setup.
The Board of Directors of the Company at its meeting held May 19, 2026, has approved the same.
